@misc{indiciae3f1df3a99510,
  title = {Therapeutic benefits of maintaining CDK4/6 inhibitors and incorporating CDK2 inhibitors beyond progression in breast cancer},
  author = {Armand, J. and Kim, S. and Kim, K. and Son, E. and Kim, M. and Yang, H. W.},
  year = {2024},
  doi = {10.1101/2024.11.11.623139},
  url = {https://www.biorxiv.org/content/10.1101/2024.11.11.623139v1},
  note = {Source identifier: 10.1101/2024.11.11.623139}
}